Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19

BACKGROUND: Patients with severe coronavirus disease 2019 (COVID-19) develop acute respiratory distress and multi-system organ failure and are associated with poor prognosis and high mortality. Thus, there is an urgent need to identify early diagnostic and prognostic biomarkers to determine the risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Guohui, Gan, Xing, Wu, Zhiqiang, Xie, Dan, Xiong, Yan, Hua, Lin, Zhou, Bing, Zhou, Nanjin, Xiang, Jie, Li, Junming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532789/
https://www.ncbi.nlm.nih.gov/pubmed/33045571
http://dx.doi.org/10.1016/j.intimp.2020.107065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532789/
https://www.ncbi.nlm.nih.gov/pubmed/33045571
http://dx.doi.org/10.1016/j.intimp.2020.107065

Ejemplares similares